Showing 31 - 40 of 77
The problem of obtaining fair pricing for generic drugs has led to a series of regulatory measures in Canadian provinces. This paper offers a new way of thinking about the problems that need to be addressed, by considering three core components of the value chain of getting generic drugs to...
Persistent link: https://www.econbiz.de/10008595868
Persistent link: https://www.econbiz.de/10006191166
Persistent link: https://www.econbiz.de/10005941807
Persistent link: https://www.econbiz.de/10006084130
Persistent link: https://www.econbiz.de/10006830793
Persistent link: https://www.econbiz.de/10008414865
Persistent link: https://www.econbiz.de/10007688133
Persistent link: https://www.econbiz.de/10007864874
Persistent link: https://www.econbiz.de/10007728240
Persistent link: https://www.econbiz.de/10007642090